Secukinumab Cuts Symptoms of Ankylosing Spondylitis
Two trials show benefits for 150 mg subcutaneous secukinumab with IV, subcutaneous loading
Selexipag Linked to Reduced Risk of Death, Complications in PAH
Reduced risk of composite of death or pulmonary arterial hypertension-linked complications
FDA Approves Zurampic for the Treatment of Gout
Drug helps control blood levels of uric acid
Few Get Rx to Help Quit Smoking After COPD Hospitalization
Treatment not associated with cessation at six to 12 months; differences between medications
Two Draft Statements From USPSTF Open for Comment
Insufficient evidence for lipid screening in children; recommendation for statins varies with age, risk
FDA Lifts Ban on Blood Donations by Men Who Have Sex With Men
National blood surveillance system will help agency ensure safety of the blood supply
FDA Approves Uptravi for Pulmonary Arterial Hypertension
Drug found to limit worsening of the disease and reduce the need for hospitalization
Cryotherapy + Imiquimod Active in Cutaneous Melanoma Mets
Complete responses observed in patients with locoregional cutaneous metastases of melanoma
Affordable Care Act Has Improved Access to Care, Affordability
However, gaps in access to care and affordability still seen, especially for low-income adults
Pembrolizumab Shows Promise in Metastatic NSCLC
In study, the immune-based therapy beat docetaxel with fewer side effects
